Summary

Australia neurosurgery market is expected to reach USD 413.61 million by 2032 from USD 215.38 million in 2024, growing with a substantial CAGR of 8.5% in the forecast period of 2025 to 2032.

Market Segmentation:
Australia Neurosurgery Market, By Application (Trauma Surgery, Spinal Neurosurgery, Tumor Resection, Vascular Surgery, Functional Neurosurgery, and Pediatric Neurosurgery), Technology (Minimally Invasive Tools, Imaging Systems, Navigation Systems, Intra-Operative Ultrasound Systems, and Others), Clinical Setting (Urban Neurosurgery Centers, Suburban and Regional Centers, and Remote Area Clinics), End User (Hospitals, Specialty Neurosurgery Centers, Academic and Research Institutes, and Ambulatory Surgical Centers (ASCs)) - Industry Trends and Forecast to 2032

Overview of Australia Neurosurgery Market Dynamics:

Driver

• Technological advancements in neurosurgical processes
Restraint

• Limited access to healthcare in rural areas
Opportunity

• Rising adoption of telemedicine

Market Players:

The key market players operating in the Australia neurosurgery market are listed below:

• Medtronic
• Integra LifeSciences Corporation
• GE HealthCare
• Siemens Healthineers AG
• Stryker
• FUJIFILM Holdings Corporation
• Zimmer Biomet
• Elekta
• Brainlab AG
• Synaptive Medical

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW OF THE AUSTRALIA NEUROSURGERY MARKET 10
1.4 LIMITATIONS 11
1.5 MARKETS COVERED 11
2 MARKET SEGMENTATION 13
2.1 MARKETS COVERED 13
2.2 GEOGRAPHICAL SCOPE 14
2.3 YEARS CONSIDERED FOR THE STUDY 14
2.4 CURRENCY AND PRICING 14
2.5 DBMR TRIPOD DATA VALIDATION MODEL 15
2.6 MULTIVARIATE MODELING 18
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 19
2.8 DBMR MARKET POSITION GRID 20
2.9 MARKET END USER COVERAGE GRID 21
2.10 DBMR VENDOR SHARE ANALYSIS 22
2.11 SECONDARY SOURCES 23
2.12 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 28
4.1 PORTER’S FIVE FORCES 29
4.2 PESTEL ANALYSIS 30
4.3 HEALTHCARE EXPENDITURE WITH A FOCUS ON NEUROSURGERY 31
4.3.1 PROCEDURES 31
4.3.2 ENDARTERECTOMY (REMOVAL ARTERY LINING BLOCKAGE) 31
4.4 NEUROSURGERY VOLUME TREND 32
4.5 EPIDEMIOLOGY 33
5 AUSTRALIA NEUROSURGERY MARKET: REGULATIONS 34
6 MARKET OVERVIEW 35
6.1 DRIVERS 37
6.1.1 TECHNOLOGICAL ADVANCEMENTS IN NEUROSURGICAL PROCESSES 37
6.1.2 RESEARCH AND INNOVATION IN NEUROSCIENCE 37
6.1.3 RISE IN AGING POPULATION 38
6.1.4 GOVERNMENT POLICIES SUPPORTING PUBLIC HEALTH 39
6.2 RESTRAINTS 39
6.2.1 LIMITED ACCESS TO HEALTHCARE IN RURAL AREAS 39
6.2.2 CONCERNS ASSOCIATED WITH POST-SURGICAL COMPLICATIONS 40
6.3 OPPORTUNITIES 41
6.3.1 RISING ADOPTION OF TELEMEDICINE 41
6.3.2 RISE IN INNOVATIVE TREATMENT OPTIONS 41
6.3.3 INCREASE IN THE NUMBER OF COLLABORATIONS AND PARTNERSHIPS AMONG UNIVERSITIES AND HOSPITALS 42
6.4 CHALLENGES 42
6.4.1 SHORTAGE OF QUALIFIED NEUROSURGEONS 42
6.4.2 HIGH COSTS ASSOCIATED WITH NEUROSURGICAL TRAINING 43
7 AUSTRALIA NEUROSURGERY MARKET, BY APPLICATION 44
7.1 OVERVIEW 45
7.2 TRAUMA SURGERY 48
7.2.1 TRAUMATIC BRAIN SURGERY 48
7.2.2 SPINAL CORD INJURY 48
7.3 SPINAL NEUROSURGERY 48
7.3.1 DEGENERATIVE SPINAL DISORDERS 48
7.3.2 SPINAL TUMORS 48
7.4 TUMOR RESECTION 48
7.4.1 PRIMARY BRAIN TUMORS 49
7.4.2 METASTATIC BRAIN TUMORS 49
7.5 VASCULAR SURGERY 49
8 AUSTRALIA NEUROSURGERY MARKET, BY CLINICAL SETTING 50
8.1 OVERVIEW 51
8.2 URBAN NEUROSURGERY CENTERS 54
8.3 SUBURBAN AND REGIONAL CENTERS 54
8.4 REMOTE AREA CLINICS 54
9 AUSTRALIA NEUROSURGERY MARKET, BY TECHNOLOGY 55
9.1 OVERVIEW 56
9.2 MINIMALLY INVASIVE TOOLS 59
9.2.1 ENDOSCOPES 59
9.2.2 ROBOTIC-ASSISTED SURGICAL SYSTEMS 59
9.3 IMAGING SYSTEMS 59
9.3.1 MRI-GUIDED SYSTEMS 59
9.3.2 CT-GUIDED SYSTEMS 59
9.4 NAVIGATION SYSTEMS 60
9.5 INTRA-OPERATIVE ULTRASOUND SYSTEMS 60
9.6 OTHERS 60
10 AUSTRALIA NEUROSURGERY MARKET, BY END USER 61
10.1 OVERVIEW 62
10.2 HOSPITALS 65
10.3 PUBLIC 65
10.4 PRIVATE 65
10.4.1 SPECIALTY NEUROSURGERY CENTERS 65
10.4.2 ACADEMIC AND RESEARCH INSTITUTES 65
10.4.3 AMBULATORY SURGICAL CENTERS (ASCS) 65
11 AUSTRALIA NEUROSURGERY MARKET: COMPANY LANDSCAPE 66
11.1 COMPANY SHARE ANALYSIS: AUSTRALIA 66
12 SWOT ANALYSIS 67
13 COMPANY PROFILES 68
13.1 MEDTRONIC 68
13.1.1 COMPANY SNAPSHOT 68
13.1.2 REVENUE ANALYSIS 68
13.1.3 PRODUCT PORTFOLIO 69
13.1.4 RECENT DEVELOPMENT 69
13.2 INTEGRA LIFESCIENCES CORPORATION 70
13.2.1 COMPANY SNAPSHOT 70
13.2.2 REVENUE ANALYSIS 70
13.2.3 PRODUCT PORTFOLIO 71
13.2.4 RECENT DEVELOPMENT 71
13.3 GE HEALTHCARE 72
13.3.1 COMPANY SNAPSHOT 72
13.3.2 REVENUE ANALYSIS 72
13.3.3 PRODUCT PORTFOLIO 73
13.3.4 RECENT DEVELOPMENT 75
13.4 SIEMENS HEALTHINEERS AG 76
13.4.1 COMPANY SNAPSHOT 76
13.4.2 REVENUE ANALYSIS 76
13.4.3 PRODUCT PORTFOLIO 77
13.4.4 RECENT DEVELOPMENT 80
13.5 STRYKER 81
13.5.1 COMPANY SNAPSHOT 81
13.5.2 REVENUE ANALYSIS 81
13.5.3 PRODUCT PORTFOLIO 82
13.5.4 RECENT DEVELOPMENT 82
13.6 BRAINLAB AG 83
13.6.1 COMPANY SNAPSHOT 83
13.6.2 PRODUCT PORTFOLIO 83
13.6.3 RECENT DEVELOPMENT 83
13.7 ELEKTA 85
13.7.1 COMPANY SNAPSHOT 85
13.7.2 REVENUE ANALYSIS 85
13.7.3 PRODUCT PORTFOLIO 86
13.7.4 RECENT DEVELOPMENT 86
13.8 FUJIFILM HOLDINGS CORPORATION 87
13.8.1 COMPANY SNAPSHOT 87
13.8.2 REVENUE ANALYSIS 87
13.8.3 PRODUCT PORTFOLIO 88
13.8.4 RECENT DEVELOPMENT 91
13.9 SYNAPTIVE MEDICAL 92
13.9.1 COMPANY SNAPSHOT 92
13.9.2 PRODUCT PORTFOLIO 92
13.9.3 RECENT DEVELOPMENT 93
13.10 ZIMMER BIOMET 94
13.10.1 COMPANY SNAPSHOT 94
13.10.2 REVENUE ANALYSIS 94
13.10.3 PRODUCT PORTFOLIO 95
13.10.4 RECENT DEVELOPMENT 95
14 QUESTIONNAIRE 96
15 RELATED REPORTS 99